These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445 [TBL] [Abstract][Full Text] [Related]
6. Signaling molecules in nonfamilial pulmonary hypertension. Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257 [TBL] [Abstract][Full Text] [Related]
7. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Machado RD; Pauciulo MW; Thomson JR; Lane KB; Morgan NV; Wheeler L; Phillips JA; Newman J; Williams D; Galiè N; Manes A; McNeil K; Yacoub M; Mikhail G; Rogers P; Corris P; Humbert M; Donnai D; Martensson G; Tranebjaerg L; Loyd JE; Trembath RC; Nichols WC Am J Hum Genet; 2001 Jan; 68(1):92-102. PubMed ID: 11115378 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357 [TBL] [Abstract][Full Text] [Related]
15. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267 [TBL] [Abstract][Full Text] [Related]
16. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Beppu H; Ichinose F; Kawai N; Jones RC; Yu PB; Zapol WM; Miyazono K; Li E; Bloch KD Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1241-7. PubMed ID: 15286002 [TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta superfamily receptors in rat eyes. Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529 [TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. De Caestecker M; Meyrick B Respir Res; 2001; 2(4):193-7. PubMed ID: 11686884 [TBL] [Abstract][Full Text] [Related]
19. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Nishihara A; Watabe T; Imamura T; Miyazono K Mol Biol Cell; 2002 Sep; 13(9):3055-63. PubMed ID: 12221115 [TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]